Probiotics enhance the clearance of human papillomavirus-related cervical lesions: a prospective controlled pilot study.

Veronique Verhoeven, Nathalie Renard, Amin Makar, Paul Van Royen, John-Paul Bogers, Filip Lardon, Marc Peeters, Marc Baay

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2013;22(1):46-51

PMID: 22706167

Abstract

Probiotics have been proposed for a number of urogenital infectious conditions. In this study, we examine a possible effect on human papillomavirus (HPV)-related precancerous lesions in cervical cytology. We conducted a prospective controlled pilot study, in which 54 women with an HPV+low-grade squamous intraepithelial lesion diagnosis in their PAP smear were followed for 6 months. The intervention group consumed a daily probiotic drink during the study period; the control group received no treatment, according to common care policy. Outcome measures were the control PAP smear and HPV status after 6 months. Probiotic users had a twice as high chance of clearance of cytological abnormalities (60 vs. 31%, P=0.05). HPV was cleared in 19% of control patients versus 29% of probiotic users (P=0.41). This exploratory pilot study suggests that the probiotic studied promotes the clearance of HPV-related cytological abnormalities. If confirmed, this would represent an entirely new option to manage cervical cancer precursors.

Address: Department of Primary and Interdisciplinary Care, Faculty of Medicine and Health Sciences, University of Antwerp, University Square 1, Wilrijk, Belgium. [email protected]
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.